Dawnrays Pharmaceutical (Holdings) Limited 2348.HK Stock
Dawnrays Pharmaceutical (Holdings) Limited Price Chart
Dawnrays Pharmaceutical (Holdings) Limited 2348.HK Financial and Trading Overview
Contents
- Dawnrays Pharmaceutical (Holdings) Limited Price Chart
- Dawnrays Pharmaceutical (Holdings) Limited 2348.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Dawnrays Pharmaceutical (Holdings) Limited
- Q&A For Dawnrays Pharmaceutical (Holdings) Limited Stock
| Dawnrays Pharmaceutical (Holdings) Limited stock price | 1.19 HKD |
| Previous Close | 1.27 HKD |
| Open | 1.25 HKD |
| Bid | 1.25 HKD x 0 |
| Ask | 1.26 HKD x 0 |
| Day's Range | 1.2 - 1.26 HKD |
| 52 Week Range | 0.98 - 1.47 HKD |
| Volume | 708K HKD |
| Avg. Volume | 180.59K HKD |
| Market Cap | 1.87B HKD |
| Beta (5Y Monthly) | 0.841379 |
| PE Ratio (TTM) | 4.8076925 |
| EPS (TTM) | 0.24 HKD |
| Forward Dividend & Yield | 0.09 (6.87%) |
| Ex-Dividend Date | May 30, 2023 |
| 1y Target Est | N/A |
2348.HK Valuation Measures
| Enterprise Value | 852.94M HKD |
| Trailing P/E | 4.8076925 |
| Forward P/E | 2.840909 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4663174 |
| Price/Book (mrq) | 0.7090187 |
| Enterprise Value/Revenue | 0.668 |
| Enterprise Value/EBITDA | 1.811 |
Trading Information
Dawnrays Pharmaceutical (Holdings) Limited Stock Price History
| Beta (5Y Monthly) | 0.841379 |
| 52-Week Change | 5.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.47 HKD |
| 52 Week Low | 0.98 HKD |
| 50-Day Moving Average | 1.32 HKD |
| 200-Day Moving Average | 1.24 HKD |
2348.HK Share Statistics
| Avg. Volume (3 month) | 180.59K HKD |
| Avg. Daily Volume (10-Days) | 246K HKD |
| Shares Outstanding | 1.5B |
| Float | 600.34M |
| Short Ratio | N/A |
| % Held by Insiders | 61.04% |
| % Held by Institutions | 11.89% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.078 |
| Trailing Annual Dividend Yield | 6.14% |
| 5 Year Average Dividend Yield | 444.00% |
| Payout Ratio | 0.2887 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 28.02% |
| Operating Margin (ttm) | 32.09% |
| Gross Margin | 60.00% |
| EBITDA Margin | 36.86% |
Management Effectiveness
| Return on Assets (ttm) | 7.30% |
| Return on Equity (ttm) | 14.09% |
Income Statement
| Revenue (ttm) | 1.28B HKD |
| Revenue Per Share (ttm) | 0.85 HKD |
| Quarterly Revenue Growth (yoy) | 17.50% |
| Gross Profit (ttm) | 766.68M HKD |
| EBITDA | 470.98M HKD |
| Net Income Avi to Common (ttm) | 358.06M HKD |
| Diluted EPS (ttm) | 0.26 |
| Quarterly Earnings Growth (yoy) | -2.70% |
Balance Sheet
| Total Cash (mrq) | 1.08B HKD |
| Total Cash Per Share (mrq) | 0.72 HKD |
| Total Debt (mrq) | 8.41M HKD |
| Total Debt/Equity (mrq) | 0.32 HKD |
| Current Ratio (mrq) | 1.871 |
| Book Value Per Share (mrq) | 1.763 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 434.27M HKD |
| Levered Free Cash Flow (ttm) | 359.5M HKD |
Profile of Dawnrays Pharmaceutical (Holdings) Limited
| Country | Hong Kong |
| State | N/A |
| City | Wan Chai |
| Address | CNT Tower |
| ZIP | N/A |
| Phone | 852 2111 9708 |
| Website | https://www.dawnrays.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1106 |
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong.
Q&A For Dawnrays Pharmaceutical (Holdings) Limited Stock
What is a current 2348.HK stock price?
Dawnrays Pharmaceutical (Holdings) Limited 2348.HK stock price today per share is 1.19 HKD.
How to purchase Dawnrays Pharmaceutical (Holdings) Limited stock?
You can buy 2348.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dawnrays Pharmaceutical (Holdings) Limited?
The stock symbol or ticker of Dawnrays Pharmaceutical (Holdings) Limited is 2348.HK.
Which industry does the Dawnrays Pharmaceutical (Holdings) Limited company belong to?
The Dawnrays Pharmaceutical (Holdings) Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dawnrays Pharmaceutical (Holdings) Limited have in circulation?
The max supply of Dawnrays Pharmaceutical (Holdings) Limited shares is 1.5B.
What is Dawnrays Pharmaceutical (Holdings) Limited Price to Earnings Ratio (PE Ratio)?
Dawnrays Pharmaceutical (Holdings) Limited PE Ratio is 4.95833350 now.
What was Dawnrays Pharmaceutical (Holdings) Limited earnings per share over the trailing 12 months (TTM)?
Dawnrays Pharmaceutical (Holdings) Limited EPS is 0.24 HKD over the trailing 12 months.
Which sector does the Dawnrays Pharmaceutical (Holdings) Limited company belong to?
The Dawnrays Pharmaceutical (Holdings) Limited sector is Healthcare.